The metabolomics market size is expected to grow at compounded annual growth rate (CAGR) of 14.9% during the forecast period.

At present, around 180 players across the globe claim to have the required capabilities to offer metabolomics services for biological analysis and profiling of small molecules.

During our research we were able to identify about 180 players, that are actively engaged in providing metabolomics services. Majority of the metabolomics service providers are non-industry players. This could be attributed to the fact that the domain requires high-end expertise and significant investment, however, the return on such lucrative investments is limited.

During our research, we observed that majority the players offer both study design and sample preparation services; notable examples include Afekta Technologies and SGS.

Furthermore, targeted metabolomics emerged as the most common type of metabolomics service offered by both industry and non-industry players; examples of start-ups (small and very small firms) offering this service include (in alphabetical order, based in Asia), BioXenClue, Cytomics, Novelgene Technologies. Additionally, we came across companies that provide untargeted metabolomics services.

The metabolomics services market is highly fragmented, featuring the presence of very small / small, mid-sized, large / very large companies. Further, majority of the companies are based in North America, followed by those headquartered in Europe. This can be attributed to the favorable environment and regulatory landscape offered by these geographies, which further enables the sponsors to outsource their business processes without much concern regarding safety and quality.

During our research, we observed that majority of the service providers offer metabolomics services using mass spectrometry, followed by nuclear magnetic resonance. Out of the players which employ mass spectrometry, majority of the players utilize liquid chromatography-based separation technique.

Furthermore, maximum number of players offer metabolomics services for biomarker discovery; examples include DNA Xperts and Novelgene Technologies. This is followed by companies that perform metabolomics studies for disease diagnostics, toxicological testing, drug discovery and personalized medicine purposes. Examples of players offering metabolomics solutions to support disease diagnostics include Evotec and Synbio Technologies.

In order to outshine their services and drive compliance to evolving industry benchmarks, providers are keen to integrate advanced technologies and ink strategic agreements that can attract a wider audience

In order to determine the relative competitiveness of metabolomics service providers, we focused on several relevant parameters, such as, service portfolio strength (in terms of number of pre-profiling services offered, number of additional services offered, type metabolome profiling technique used, type of approach used for data analysis, type of biological sample analyzed, source of biological sample analyzed and area of application) and partnership strength (in terms of number of partnerships and type of agreement).

Additionally, the insights on company competitiveness have been presented in the form of a3D bubble chart, with the company’s experience on the x-axis and competitiveness on the y-axis. Further, the size of the bubble indicates the number of metabolomics services offered by the company.

The most prominent player based on company competitiveness offers a wide range of metabolomics services, including experimental design, sample preparation, targeted metabolomics and untargeted metabolomics for biomarker discovery, drug discovery and personalized medicine applications. In addition, the company has signed partnerships during the period 2014-2022. Examples of other prominent small players in this domain include Proteomics and Synbio Technologies. It is also worth mentioning that a majority of firms in this peer group are based in North America.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/metabolomics-services-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.             

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact Details

Roots Analysis 

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

[email protected] 

Website: https://www.rootsanalysis.com/